Adaptin Bio (APTN) Other Accumulated Expenses (2022 - 2025)

Adaptin Bio's Other Accumulated Expenses history runs 4 years deep, the most recent figure standing at $12576.0 for Q1 2025.

• In Q1 2025, Other Accumulated Expenses fell 65.31% year-over-year to $12576.0; the TTM figure through Mar 2025 stood at $12576.0 (down 65.31% YoY), while the FY2023 annual figure was $32000.0, up 113.33% from the prior year.
• Other Accumulated Expenses came in at $12576.0 for Q1 2025 at Adaptin Bio, down from $44750.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $44750.0 in Q3 2024 to a low of $12576.0 in Q1 2025.
• A 4-year average of $30179.3 and a median of $34125.0 in 2023 frame the typical range for Other Accumulated Expenses.
• Across the five-year window, Other Accumulated Expenses surged 113.33% in 2023 and tumbled 65.31% in 2025, its largest moves.
• Adaptin Bio's Other Accumulated Expenses stood at $15000.0 in 2022, then soared by 113.33% to $32000.0 in 2023, then soared by 39.84% to $44750.0 in 2024, then slumped by 71.9% to $12576.0 in 2025.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $12576.0, $44750.0, and $40500.0 for Q1 2025, Q3 2024, and Q2 2024 respectively.

Peer Comparison